The Fundación Española para la Ciencia y la Tecnología (FECYT) received 881 proposals from 383 public and private organisations for the call, which offers a total funding pot of €3,25 million for ideas and activities aimed at the promotion of scientific culture, technology and innovation.
IBEC’s Molecular and Cellular Neurobiotechnology group is to receive funding from 2013’s La Marató de TV3 for their project “Role of the cellular prion protein as “cross-talk” protein between a-syn/ LRRK2 and p-Tau in sporadic and familiar Parkinson´s disease.”The group’s proposal was one of 44 selected for funding under the annual award, which in its 2013 call focused on neurodegenerative diseases.
Not only that, but the institute was ranked top among the applicants, meaning it will receive one of the two largest portions of the total grant money, the other going to the ISCIII.
Tomorrow night IBEC group leader and ICREA professor Ángel Raya will give a public lecture at the CCCB in Barcelona entitled “Células madre y medicina regenerativa: realidades y promesas” (“Stem cells and regenerative medicine: realities and promises”). Ángel, who is also director of the Barcelona Centre for Regenerative Medicine (CMRB), is contributing the lecture as part of the fourth ICREA-CCCB Debates series, taking place from 21 October to 11 November, which this year is devoted to “Stem Cells: a Future without Diseases?”.
IBEC’s Core Facilities have been included in MINECO’s updated ICTS (Infraestructuras Científicas y Técnicas Singulares) map as part of NANBIOSIS, an integrated platform for research-oriented medical applications. Created by combining the service platforms within the CIBER-BBN and CCMIJU (the Center for Minimally Invasive Surgery Jesus Uson), NANBIOSIS (Infraestructuras Integrada de Producción y Caracterización de Nanomateriales, Biomateriales y Sistemas en Biomedicina) aims to be a ‘one-stop-shop’ service facility for the design and production of biomaterials and nanomaterials, among other applications.
IBEC is participating this week in Expoquimia, the international chemistry trade show whose 17th edition is taking place from 30 September to 3 October at the Fira Gran Via in Barcelona.Expoquimia is attended by the leading companies and organizations in the international chemical industry such as BASF, BAYER, Dow Chemical, ICL, REPSOL and SOLVAY. The Fira’s three halls open their doors at 10am today, kicking off a program of workshops, seminars and conferences, as well as the trade exhibition.
The 7th annual IBEC Symposium is fast approaching!This year the theme will be ‘Bioengineering for Future Medicine’, which is one of the institute’s three main areas of application.
The latest article published by IBEC’s Nanoscale bioelectrical characterization group has made the cover of the journal Nanotechnology. The paper, “Finite-size effects and analytical modeling of electrostatic force microscopy applied to dielectric films”, presents a model for the accurate quantification of EFM measurements on dielectric films on metallic substrates.
IBEC’s Xavier Fernández-Busquets appears in a video produced by the EU-funded ERA-NET project EuroNanoMed on “Drug Delivery: The Use of Nanoparticles in Medicine”.It’s the second in a series of videos featuring scientists working in the field of nanomedicine which are being produced for EuroNanoMed by its Israeli partner, the Chief Scientist Office of the country’s Ministry of Health (CSO-MOH).
This week, 24 young researchers from Spain, Italy, Portugal and even further afield are at IBEC to learn about the state-of-the-art of stem cell research and regenerative medicine, as well as learning some essential lab techniques, in the fourth “Interrogations at the Biointerface” Advanced Summer School.The Summer School, which is co-organised annually by IBEC, the Instituto de Engenharia Biomédica (INEB) and the Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUB), both in Portugal, features a stellar line-up of speakers for three days and then introduces PhD students and early postdocs to advanced experimental techniques for a day.